Immunohistochemical Evaluation of Adenomatous Polyposis Coli, β-Catenin, c-Myc, Cyclin D1, p53, and Retinoblastoma Protein Expression in Syndromic and Sporadic Fundic Gland Polyps

Human Pathology

Volumn 35, Issue 3, 2004, Pages 328-334

  Hassan, Anjum ^b   Yerian, Lisa M ^b   Kuan, Shih Fan ^b   Xiao, Shu Yuan ^b   Hart, John ^b   Wang, Hanlin L ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

APC; c Myc; Cyclin D1; Fundic gland polyp; Immunohistochemistry; p53; RB; catenin

Indexed keywords

APC PROTEIN; BETA CATENIN; CYCLIN D1; MYC PROTEIN; PROTEIN P53; RETINOBLASTOMA PROTEIN;

ADENOMATOUS POLYP; ADOLESCENT; ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER RISK; CARBOXY TERMINAL SEQUENCE; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DYSPLASIA; EVALUATION; FAMILIAL COLON POLYPOSIS; FEMALE; GARDNER SYNDROME; GASTROESOPHAGEAL REFLUX; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MALIGNANT TRANSFORMATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SOMATIC MUTATION; STOMACH CARCINOGENESIS; STOMACH POLYP; TRANSCRIPTION REGULATION;

EID: 1542720307     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humpath.2003.10.010     Document Type: Article

References (44)

1. Declich P, Ambrosiani L, Grassini R, et al: Fundic gland polyps: A still elusive entity on the eve of the year 2000. Pol J Pathol 51:3-8, 2000
2. Choudhry U, Boyce HW Jr, Coppola D: Proton pump inhibitor-associated gastric polyps: A retrospective analysis of their frequency, and endoscopic, histologic, and ultrastructural characteristics. Am J Clin Pathol 110:615-621, 1998
3. Vieth M, Stolte M: Fundic gland polyps are not induced by proton pump inhibitor therapy. Am J Clin Pathol 116:716-720, 2001
4. Odze RD, Marcial MA, Antonioli D: Gastric fundic gland polyps: A morphological study including mucin histochemistry, stereometry, and MIB-1 immunohistochemistry. HUM PATHOL 27:896-903, 1996
5. Declich P, Tavani E, Bellone S, et al: Sporadic, syndromic, and Zollinger-Ellison syndrome associated fundic gland polyps consistently express cytokeratin 7. Virchows Arch 441:96-97, 2002
6. Toyooka M, Konishi M, Kikuchi-Yanoshita R, et al: Somatic mutations of the adenomatous polyposis coli gene in gastroduodenal tumors from patients with familial adenomatous polyposis. Cancer Res 55:3165-3170, 1995
7. Abraham SC, Nobukawa B, Giardiello FM, et al: Fundic gland polyps in familial adenomatous polyposis: Neoplasms with frequent somatic adenomatous polyposis coli gene alterations. Am J Pathol 157:747-754, 2000
8. Abraham SC, Nobukawa B, Giardiello FM, et al: Sporadic fundic gland polyps: Common gastric polyps arising through activating mutations in the β-catenin gene. Am J Pathol 158:1005-1010, 2001
9. Torbenson M, Lee JH, Cruz-Correa M, et al: Sporadic fundic gland polyposis: A clinical, histological, and molecular analysis. Mod Pathol 15:718-723, 2002
10. Sekine S, Shibata T, Yamauchi Y, et al: β-Catenin mutations in sporadic fundic gland polyps. Virchows Arch 440:381-386, 2002
11. Chung DC: The genetic basis of colorectal cancer: Insights into critical pathways of tumorigenesis. Gastroenterology 119:854-865, 2000
12. Wu TT, Kornacki S, Rashid A, et al: Dysplasia and dysregulation of proliferation in foveolar and surface epithelia of fundic gland polyps from patients with familial adenomatous polyposis. Am J Surg Pathol 22:293-298, 1998
13. Bertoni G, Sassatelli R, Nigrisoli E, et al: Dysplastic changes in gastric fundic gland polyps of patients with familial adenomatous polyposis. Ital J Gastroenterol Hepatol 31:192-197, 1999
14. Attard TM, Yardley JH, Cuffari C: Gastric polyps in pediatrics: An 18-year hospital-based analysis. Am J Gastroenterol 97:298-301, 2002
15. Abraham SC, Park SJ, Mugartegui L, et al: Sporadic fundic gland polyps with epithelial dysplasia: Evidence for preferential targeting for mutations in the adenomatous polyposis coli gene. Am J Pathol 161:1735-1742, 2002
16. Odze RD, Quinn PS, Terrault NA, et al: Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis. HUM PATHOL 24:442-448, 1993
17. Zwick A, Munir M, Ryan CK, et al: Gastric adenocarcinoma and dysplasia in fundic gland polyps of a patient with attenuated adenomatous polyposis coli. Gastroenterology 113:659-663, 1997
18. Hofgärtner WT, Thorp M, Ramus MW, et al: Gastric adenocarcinoma associated with fundic gland polyps in a patient with attenuated familial adenomatous polyposis. Am J Gastroenterol 94: 2275-2281, 1999
19. Attard TM, Giardiello FM, Argani P, et al: Fundic gland polyposis with high-grade dysplasia in a child with attenuated familial adenomatous polyposis and familial gastric cancer. J Pediatr Gastroenterol Nutr 32:215-218, 2001
20. Montgomery E, Goldblum JR, Greenson JK, et al: Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: A follow-up study based on 138 cases from a diagnostic variability study. HUM PATHOL 32:379-388, 2001
21. Wang HL, Lu DW, Yerian LM, et al: Immunohistochemical distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Am J Surg Pathol 25:1380-1387, 2001
22. Wang HL, Wang J, Xiao SY, et al: Elevated protein expression of cyclin D1 and Fra-1 but decreased expression of c-Myc in human colorectal adenocarcinomas overexpressing β-catenin. Int J Cancer 101:301-310, 2002
23. Chop AM, Abraham CL, Adrian TE, et al: Immunodetection of the presence or absence of full-length APC gene product in human colonic tissues. Anticancer Res 15:991-997, 1995
24. Kemler R: From cadherins to catenins: Cytoplasmic protein interactions and regulation of cell adhesion. Trends Genet 9:317-321, 1993
25. He TC, Sparks AB, Rago C, et al: Identification of c-MYC as a target of the APC pathway. Science 281:1509-1512, 1998
26. Tetsu O, McCormick F: β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398:422-426, 1999
27. Shtutman M, Zhurinsky J, Simcha I, et al: The cyclin D1 gene is a target of the β-catenin/LEF-1 pathway. Proc Natl Acad Sci U S A 96:5522-5527, 1999
28. Morin PJ, Sparks AB, Korinek V, et al: Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 275:1787-1790, 1997
29. Sparks AB, Morin PJ, Vogelstein B, et al: Mutational analysis of the APC/β-catenin/Tcf pathway in colorectal cancer. Cancer Res 58:1130-1134, 1998
30. Wong NA, Pignatelli M: β-Catenin-a linchpin in colorectal carcinogenesis? Am J Pathol 160:389-401, 2002
31. Neufeld KL, White RL: Nuclear and cytoplasmic localizations of the adenomatous polyposis coli protein. Proc Natl Acad Sci U S A 94:3034-3039, 1997
32. Rosin-Arbesfeld R, Townsley F, Bienz M: The APC tumour suppressor has a nuclear export function. Nature 406:1009-1012, 2000
33. Henderson BR: Nuclear-cytoplasmic shuttling of APC regulates β-catenin subcellular localization and turnover. Nat Cell Biol 2:653-660, 2000
34. Reinacher-Schick A, Gumbiner BM: Apical membrane localization of the adenomatous polyposis coli tumor suppressor protein and subcellular distribution of the β-catenin destruction complex in polarized epithelial cells. J Cell Biol 152:491-502, 2001
35. Coqueret O: Linking cyclins to transcriptional control. Gene 299:35-55, 2002
36. Dang CV: c-Myc target genes involved in cell growth, apoptosis, and metabolism. Mol Cell Biol 19:1-11, 1999
37. Hahn WC, Weinberg RA: Rules for making human tumor cells. N Engl J Med 347:1593-1603, 2002
38. Hall PA, Lane DP: p53 in tumour pathology: Can we trust immunohistochemistry? -Revisitedl J Pathol 172:1-4, 1994
39. Gouyer V, Gazzeri S, Brambilla E, et al: Loss of heterozygosity at the RB locus correlates with loss of RB protein in primary malignant neuro-endocrine lung carcinomas. Int J Cancer 58:818-824, 1994
40. Cagle PT, el-Naggar AK, Xu HJ, et al: Differential retinoblastoma protein expression in neuroendocrine tumors of the lung. Potential diagnostic implications. Am J Pathol 150:393-400, 1997
41. Lauwers GY, Wahl SJ, Melamed J, et al: p53 expression in precancerous gastric lesions: An immunohistochemical study of PAb 1801 monoclonal antibody on adenomatous and hyperplastic gastric polyps. Am J Gastroenterol 88:1916-1919, 1993
42. Yao T, Kajiwara M, Kuroiwa S, et al: Malignant transformation of gastric hyperplastic polyps: Alteration of phenotypes, proliferative activity, and p53 expression. HUM PATHOL 33:1016-1022, 2002
43. Younes M, Ertan A, Lechago LV, et al: p53 Protein accumulation is a specific marker of malignant potential in Barrett's metaplasia. Dig Dis Sci 42:697-701, 1997
44. Weston AP, Banerjee SK, Sharma P, et al: p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: Immunohistochemical marker predictive of progression. Am J Gastroenterol 96:1355-1362, 2001